Credit Suisse’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Credit Suisse’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-28,187	Closed	-$131K	–	4385
2016 Q3	$131K	Sell	28,187 -21,933	-44%	-$102K	﹤0.01%	3890
2016 Q2	$197K	Sell	50,120 -8,179	-14%	-$30.6K	﹤0.01%	3876
2016 Q1	$181K	Buy	58,299 +33,792	+138%	+$113K	﹤0.01%	3715
2015 Q4	$112K	Buy	+24,507	New	+$116K	﹤0.01%	4059
2015 Q3	–	Sell	-87,003	Closed	-$623K	–	4774
2015 Q2	$623K	Buy	+87,003	New	+$654K	﹤0.01%	3555
2014 Q2	–	Sell	-17,027	Closed	-$215K	–	5025
2014 Q1	$215K	Buy	+17,027	New	+$220K	﹤0.01%	4313

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Credit Suisse's DSCI Position: Q4 2016 in Review

Credit Suisse sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2016, closing a stake of 28,187 shares — an estimated $131K sold.

Credit Suisse first reported a position in DSCI in Q1 2014 and held it in 6 quarters. The position peaked at $623K in Q2 2015. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

Credit Suisse reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2016 after selling out during the quarter.
Credit Suisse sold 28,187 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $131K.
Credit Suisse first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 6 quarters.
Credit Suisse's Derma Sciences, Inc. Common Stock (DE) position peaked at $623K in Q2 2015.
52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on Credit Suisse's 13F filing for Q4 2016, filed 14 Feb 2017.